4//SEC Filing
Dable Habib J 4
Accession 0001415889-24-007100
CIK 0001798749other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 6:00 PM ET
Size
5.8 KB
Accession
0001415889-24-007100
Insider Transaction Report
Form 4
Dable Habib J
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-03-04$16.37/sh+1,531$25,062→ 1,531 totalExercise: $22.49Exp: 2034-03-04→ Common Stock (1,531 underlying)
Footnotes (1)
- [F1]This option was awarded in lieu of cash compensation pursuant to the Issuer's Non-Employee Director Compensation Policy. The shares underlying such option shall vest and become exercisable in four equal installments, with the first installment vesting on March 31, 2024, the second installment vesting on June 30, 2024, the third installment vesting on September 30, 2024, and the fourth installment vesting on December 31, 2024.
Documents
Issuer
Aerovate Therapeutics, Inc.
CIK 0001798749
Entity typeother
Related Parties
1- filerCIK 0001690773
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 6:00 PM ET
- Size
- 5.8 KB